Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value $0.01 per share
-
Shares outstanding
-
95,992,895
-
Total 13F shares
-
77,015,539
-
Share change
-
-1,907,076
-
Total reported value
-
$605,345,850
-
Put/Call ratio
-
185%
-
Price per share
-
$7.83
-
Number of holders
-
169
-
Value change
-
-$36,026,238
-
Number of buys
-
98
-
Number of sells
-
70
Institutional Holders of AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) as of Q1 2025
As of 31 Mar 2025,
AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,015,539 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, GENDELL JEFFREY L, BRANDES INVESTMENT PARTNERS, LP, BlackRock, Inc., Two Seas Capital LP, Polar Capital Holdings Plc, VANGUARD GROUP INC, Vivo Capital, LLC, WEALTH EFFECTS LLC, and CITADEL ADVISORS LLC.
This page lists
171
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.